stoxline Quote Chart Rank Option Currency Glossary
Savara Inc. (SVRA)
4.02  0.13 (3.34%)    12-07 16:00
Open: 3.88
High: 4.11
Volume: 2,798,905
Pre. Close: 3.89
Low: 3.85
Market Cap: 544(M)
Technical analysis
2023-12-07 4:23:38 PM
Short term     
Mid term     
Targets 6-month :  4.8 1-year :  5.6
Resists First :  4.11 Second :  4.8
Pivot price 3.79
Supports First :  3.49 Second :  3.11
MAs MA(5) :  3.92 MA(20) :  3.72
MA(100) :  3.63 MA(250) :  2.82
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  81.4 D(3) :  84.1
RSI RSI(14): 63.3
52-week High :  4.21 Low :  1.41
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SVRA ] has closed below upper band by 1.5%. Bollinger Bands are 8.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.11 - 4.13 4.13 - 4.15
Low: 3.8 - 3.82 3.82 - 3.84
Close: 3.99 - 4.02 4.02 - 4.05
Company Description

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Headline News

Fri, 01 Dec 2023
Savara Inc. (NASDAQ:SVRA) most popular amongst private equity firms who own 41% of the shares, institutions hold ... - Yahoo Finance

Tue, 21 Nov 2023
Savara to Present at the Piper Sandler 35th Annual Healthcare Conference - Business Wire

Wed, 08 Nov 2023
Savara to Present at the Jefferies London Healthcare Conference - Yahoo Finance

Fri, 06 Oct 2023
Savara Announces New Employment Inducement Grant - Business Wire

Mon, 11 Sep 2023
Savara Inc.'s (NASDAQ:SVRA) Path To Profitability - Yahoo Finance

Tue, 05 Sep 2023
Savara to Present at the H.C. Wainwright 25th Annual Global Investment Conference - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 135 (M)
Shares Float 58 (M)
Held by Insiders 1.9 (%)
Held by Institutions 58.8 (%)
Shares Short 3,880 (K)
Shares Short P.Month 3,870 (K)
Stock Financials
EPS -0.32
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.08
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -19.9 %
Return on Equity (ttm) -37.2 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.39
Qtrly Earnings Growth 0 %
Operating Cash Flow -44 (M)
Levered Free Cash Flow -24 (M)
Stock Valuations
PE Ratio -12.97
PEG Ratio 0
Price to Book value 3.72
Price to Sales 0
Price to Cash Flow -12.34
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android